We are live on ! Find out more
DCM

DG Capital Management Portfolio holdings

AUM $326M
1-Year Est. Return 39.67%
This Fund
S&P 500
This Quarter Est. Return
-23.29%
1 Year Est. Return
+39.67%
3 Year Est. Return
+81.23%
5 Year Est. Return
+56.79%
10 Year Est. Return
AUM
$278M
AUM Growth
-$221M
Cap. Flow
-$143M
Cap. Flow %
-51.39%
Top 10 Hldgs %
66.61%
Holding
136
New
1
Increased
12
Reduced
8
Closed
64

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 36.12%
2 Healthcare 23.46%
3 Consumer Staples 7.13%
4 Technology 6.67%
5 Materials 6.16%

Similar funds

DG Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, DG Capital Management held 136 positions worth $278M, down 44% from $500M the previous quarter. Its ten largest holdings account for 67% of the portfolio.

DG Capital Management withdrew a net $143M in Q2 2022, closing 64 positions and reducing 8 holdings. Its most notable exit was United Therapeutics, an estimated $19.5M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 36% of assets, up from 30% a quarter earlier, followed by Healthcare and Consumer Staples.

Against the trend, DG Capital Management added an estimated $6.65M to Caesars Entertainment.

  • DG Capital Management added most to Caesars Entertainment in Q2 2022, an estimated $6.65M increase.
  • DG Capital Management's biggest Q2 2022 reduction was Blueknight Energy Partners L.P., cutting an estimated $8.52M.
  • DG Capital Management fully exited United Therapeutics in Q2 2022, selling an estimated $19.5M.
  • DG Capital Management's ten largest holdings make up 67% of its $278M portfolio in Q2 2022.
  • DG Capital Management opened 1 new position and closed 64 in Q2 2022.
  • DG Capital Management's portfolio value fell 44% quarter-over-quarter to $278M.

Based on DG Capital Management's 13F filing for Q2 2022, filed 12 Aug 2022.